• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活质量参数和应对策略对化疗后恶心和呕吐的影响。

Impact of quality of life parameters and coping strategies on postchemotherapy nausea and vomiting.

机构信息

Department of Oncology/Hematology, University of Halle, Halle, Germany.

出版信息

Eur J Cancer Care (Engl). 2010 Sep;19(5):603-9. doi: 10.1111/j.1365-2354.2009.01099.x. Epub 2009 Aug 31.

DOI:10.1111/j.1365-2354.2009.01099.x
PMID:19725867
Abstract

To assess whether prechemotherapy quality of life (QoL) factors and certain coping strategies are associated with postchemotherapy nausea and vomiting (PCNV). A total of 43 chemotherapy-naïve patients scheduled to receive anti-emetic prophylaxis were enrolled in this study. QoL parameters were measured by a modified EORTC Quality of Life Questionnaire (QLQ-30). In addition, questions regarding active or passive coping strategies were asked 1 day before chemotherapy. Prechemotherapy QoL factors, coping strategies as well as other patient, disease and treatment variables were compared between the groups of patients with or without PCNV. The univariate analysis identified four QoL parameters, 'tiredness', 'impairment of daily life by pain', 'sensation of abdominal pressure and fullness' and 'impairment of social activities' as associated with PCNV. No association was found between coping strategies and PCNV. In the multivariate analysis, the factors 'impairment of social activities' and 'sensation of abdominal pressure and fullness' remained significant. Specific pretreatment QoL parameters are associated with the risk to develop PCNV. Thus, in addition to other established risk factors for PCNV, patients should be screened for these QoL factors in order to improve the control of PCNV and facilitate the selection of appropriate, individualised anti-emetic prophylaxes.

摘要

目的

评估化疗前生活质量(QoL)因素和某些应对策略是否与化疗后恶心和呕吐(PCNV)相关。

方法

共纳入 43 例拟接受止吐预防的化疗初治患者。采用改良版 EORTC 生活质量问卷(QLQ-30)评估 QoL 参数。此外,在化疗前 1 天询问有关主动或被动应对策略的问题。比较有无 PCNV 患者组的化疗前 QoL 因素、应对策略以及其他患者、疾病和治疗变量。

结果

单因素分析确定了四个与 PCNV 相关的 QoL 参数:“疲劳”、“疼痛导致日常生活受损”、“腹部压力和饱胀感”和“社会活动受损”。应对策略与 PCNV 之间无关联。多因素分析中,“社会活动受损”和“腹部压力和饱胀感”这两个因素仍具有显著意义。特定的预处理 QoL 参数与发生 PCNV 的风险相关。因此,除了其他已确定的 PCNV 危险因素外,还应针对这些 QoL 因素对患者进行筛查,以改善 PCNV 的控制并有助于选择合适的个体化止吐预防措施。

相似文献

1
Impact of quality of life parameters and coping strategies on postchemotherapy nausea and vomiting.生活质量参数和应对策略对化疗后恶心和呕吐的影响。
Eur J Cancer Care (Engl). 2010 Sep;19(5):603-9. doi: 10.1111/j.1365-2354.2009.01099.x. Epub 2009 Aug 31.
2
Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomiting.格拉司琼加地塞米松口服混悬液的止吐疗效及生活质量对恶心和呕吐风险的影响。
Onkologie. 2005 Feb;28(2):88-92. doi: 10.1159/000082523.
3
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.癌症患者化疗后恶心和呕吐的决定因素。加拿大国立癌症研究所临床试验组生活质量与症状控制委员会
J Clin Oncol. 1997 Jan;15(1):116-23. doi: 10.1200/JCO.1997.15.1.116.
4
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.尽管进行了止吐治疗,但在接受高度和中度致吐性化疗后,延迟性恶心和呕吐仍会持续降低患者的生活质量。
J Clin Oncol. 2006 Sep 20;24(27):4472-8. doi: 10.1200/JCO.2006.05.6382.
5
Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma.
Cancer Treat Rep. 1982 Aug;66(8):1601-4.
6
The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy.中度致吐性化疗后化疗后恶心呕吐对生活质量的影响。
Support Care Cancer. 1998 Jul;6(4):389-95. doi: 10.1007/s005200050182.
7
Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy.在化疗前,抑郁和功能障碍各自独立导致癌症患者生活质量下降。
Acta Oncol. 2008;47(1):56-62. doi: 10.1080/02841860701460541.
8
Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.化疗后恶心呕吐对健康相关生活质量的影响。加拿大国立癌症研究所临床试验组生活质量与症状控制委员会。
Support Care Cancer. 1997 Jul;5(4):307-13. doi: 10.1007/s005200050078.
9
Measuring chemotherapy-induced nausea and emesis.测量化疗引起的恶心和呕吐。
Cancer. 2003 Aug 1;98(3):645-55. doi: 10.1002/cncr.11540.
10
[Psychiatric studies of chemotherapy and chemotherapy-induced nausea and vomiting of patients with lung or thymic cancer].
Gan To Kagaku Ryoho. 1998 Feb;25(3):403-8.

引用本文的文献

1
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin-cyclophosphamide-based chemotherapy.评价当前标准治疗止吐药物治疗恶心和呕吐的预测因素:阿瑞匹坦在接受蒽环类药物联合环磷酰胺化疗的患者中进行的 3 期试验分析。
Support Care Cancer. 2011 Jun;19(6):807-13. doi: 10.1007/s00520-010-0899-5. Epub 2010 May 13.